drugset / Trial / NCT00682357

Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis

NCT00682357

Completed 25 enrolled University of Kansas Medical Center
RandomizedParallel-groupOpen-labelSupportive care

Summary

Oral and nasal steroids may enhance osteoporosis by suppressing bone formation. Intra-articular steroids may also suppress bone formation, however, the duration or relationship to a steroid dose has not been established. It is hypothesized that intra-articular steroids suppress bone formation transiently, returning to pretreatment levels within four weeks in subjects with osteoarthritis.

Timeline

Start
2008-05
Primary completion
2009-11
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 16 mg Intravitreal
Subject Methylprednisolone Other / unclassified 80 mg Intravitreal
Background Lidocaine Other / unclassified 20 mg

Indications